- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Aarti Drugs Limited — Updates, 09-10-2025: General Updates
09-10-2025 | 07:04 pm
09-10-2025 | 07:04 pm
Aarti Drugs received an independent 'Crisil ESG 52' rating for FY25. This score, based on public data, signals its Environmental, Social, and Governance performance for investors.
No comments yet. Be the first to comment!